scholarly article | Q13442814 |
P2093 | author name string | H A Jinnah | |
Ellen J Hess | |||
Valerie B Thompson | |||
P2860 | cites work | Basal ganglia activity remains elevated after movement in focal hand dystonia | Q80040787 |
Mutations in the BH4-metabolizing genes GTP cyclohydrolase I, 6-pyruvoyl-tetrahydropterin synthase, sepiapterin reductase, carbinolamine-4a-dehydratase, and dihydropteridine reductase | Q80135949 | ||
Disturbed surround inhibition in focal hand dystonia | Q80801818 | ||
Pallidal deep brain stimulation in the treatment of Meige syndrome | Q80860686 | ||
Cervical dystonia due to cerebellar stroke | Q80940311 | ||
Thalamic deep brain stimulation for writer's cramp | Q81540054 | ||
Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene | Q24314922 | ||
A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration | Q24337490 | ||
The neural substrates of rapid-onset Dystonia-Parkinsonism | Q24609728 | ||
Cerebellothalamocortical connectivity regulates penetrance in dystonia | Q24652781 | ||
The basal ganglia and cerebellum interact in the expression of dystonic movement | Q24653882 | ||
Dopamine function in Lesch-Nyhan disease | Q24671173 | ||
Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia | Q24676021 | ||
A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy | Q24678885 | ||
Human deafness dystonia syndrome is caused by a defect in assembly of the DDP1/TIMM8a-TIMM13 complex | Q28204687 | ||
Neuronal cell death in the visual cortex is a prominent feature of the X-linked recessive mitochondrial deafness-dystonia syndrome caused by mutations in the TIMM8a gene | Q28216119 | ||
6-Pyruvoyl-tetrahydropterin synthase deficiency with generalized dystonia and diurnal fluctuation of symptoms: a clinical and molecular study | Q28238704 | ||
Recessively inherited L-DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene | Q28270793 | ||
Dystonia and cerebellar atrophy in Cacna1a null mice lacking P/Q calcium channel activity | Q28505804 | ||
Single tottering mutations responsible for the neuropathic phenotype of the P-type calcium channel | Q28510345 | ||
Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease | Q28510609 | ||
Immunocytochemical characterization of the mitochondrially encoded ND1 subunit of complex I (NADH : ubiquinone oxidoreductase) in rat brain | Q28565020 | ||
Tottering mouse motor dysfunction is abolished on the Purkinje cell degeneration (pcd) mutant background | Q28584949 | ||
Rocker is a new variant of the voltage-dependent calcium channel gene Cacna1a | Q28588820 | ||
Altered calcium channel currents in Purkinje cells of the neurological mutant mouse leaner | Q28592431 | ||
Ablation of P/Q-type Ca(2+) channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha(1A)-subunit | Q28592875 | ||
Mitochondrial dysfunction and oxidative damage in parkin-deficient mice | Q28593859 | ||
What happened to posteroventral pallidotomy for Parkinson's disease and dystonia? | Q30371432 | ||
The role of inhibition from the left dorsal premotor cortex in right-sided focal hand dystonia | Q30448590 | ||
Inter-hemispheric inhibition is impaired in mirror dystonia | Q30482299 | ||
A final common pathway for depression? Progress toward a general conceptual framework | Q30491982 | ||
Myoclonus and tremor response to thalamic deep brain stimulation parameters in a patient with inherited myoclonus-dystonia syndrome | Q30500472 | ||
Alteration of digital representations in somatosensory cortex in focal hand dystonia | Q30538612 | ||
Pathophysiological differences between musician's dystonia and writer's cramp | Q30541247 | ||
Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia. | Q30547556 | ||
Clinical and molecular findings in a patient with a novel mutation in the deafness-dystonia peptide (DDP1) gene | Q30802791 | ||
Pallidotomy for generalized dystonia | Q30881127 | ||
Secondary cervical dystonia associated with structural lesions of the central nervous system | Q31125254 | ||
CaV2.1 channelopathies | Q33537218 | ||
Kinesigenic foot dystonia as a presenting feature of Parkinson's disease | Q33620162 | ||
Changes in the balance between motor cortical excitation and inhibition in focal, task specific dystonia | Q33734698 | ||
Toxic effects of mycotoxins in humans | Q33759778 | ||
Animal models of generalized dystonia | Q33844755 | ||
Paroxysmal dyskinesias in mice | Q33921453 | ||
Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates | Q34103541 | ||
Further case of paroxysmal exercise-induced dystonia and some insights into pathogenesis | Q34162575 | ||
Huntington's disease in children. Neuropathologic study of four cases | Q34205152 | ||
Exercise-induced dystonia as a preceding symptom of familial Parkinson's disease | Q34300379 | ||
Deep brain stimulation for generalised dystonia and spasmodic torticollis | Q34382733 | ||
A primate genesis model of focal dystonia and repetitive strain injury: I. Learning-induced dedifferentiation of the representation of the hand in the primary somatosensory cortex in adult monkeys | Q34392417 | ||
Abnormal somatosensory homunculus in dystonia of the hand | Q34480294 | ||
Dystonia in Huntington's disease: prevalence and clinical characteristics. | Q34489281 | ||
Botulinum toxin injections reduce associative plasticity in patients with primary dystonia | Q34530734 | ||
Dystonia in Parkinson's disease | Q34585274 | ||
Deep brain stimulation of the globus pallidus internus (GPI) for torsion dystonia--a report of two cases | Q34613486 | ||
Subtraction brain SPECT imaging in a patient with paroxysmal exercise-induced dystonia: role of the primary somatosensory cortex | Q34712884 | ||
Severe generalized dystonia due to primary putaminal degeneration: case report and review of the literature | Q34733153 | ||
Chronic stimulation of the globus pallidus internus for treatment of non-DYT1 generalized dystonia and choreoathetosis: 2-year follow up | Q35105659 | ||
Unilateral lesions of the globus pallidus: report of four patients presenting with focal or segmental dystonia | Q35459532 | ||
Dystonia genotypes, phenotypes, and classification | Q35543697 | ||
Dysfunction of dopaminergic pathways in dystonia | Q35543720 | ||
Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics | Q35661061 | ||
Dopa responsive dystonia: a treatable condition misdiagnosed as cerebral palsy | Q35710959 | ||
Genetic clues to the pathogenesis of Parkinson's disease | Q35844782 | ||
The functional neuroanatomy of dystonia | Q36340491 | ||
The value of animal models for drug development in multiple sclerosis. | Q36458937 | ||
Lost in translation: treatment trials in the SOD1 mouse and in human ALS. | Q36735871 | ||
Subthalamic nucleus stimulation for primary dystonia and tardive dystonia. | Q36906858 | ||
Low-frequency oscillations in the cerebellar cortex of the tottering mouse | Q37086565 | ||
A novel recurrent mitochondrial DNA mutation in ND3 gene is associated with isolated complex I deficiency causing Leigh syndrome and dystonia | Q79412625 | ||
A heteroplasmic mitochondrial complex I gene mutation in adult-onset dystonia | Q44447455 | ||
Positron emission tomography scanning in essential blepharospasm | Q44641584 | ||
GABAergic inhibition of neuronal activity in the primate motor and premotor cortex during voluntary movement | Q44780543 | ||
Regional metabolism in primary torsion dystonia: effects of penetrance and genotype | Q44865998 | ||
Behavioral deficits induced by local injection of bicuculline and muscimol into the primate motor and premotor cortex | Q44915269 | ||
Increased excitability in cortico-striatal synaptic pathway in a model of paroxysmal dystonia | Q44944518 | ||
Abnormalities of dopaminergic neurotransmission in SCA2: a combined 123I-betaCIT and 123I-IBZM SPECT study | Q45076635 | ||
Two novel CACNA1A gene mutations associated with episodic ataxia type 2 and interictal dystonia | Q45265072 | ||
Dystonia-predominant adult-onset Huntington disease: association between motor phenotype and age of onset in adults | Q45301214 | ||
Reciprocal inhibition between forearm muscles in patients with writer's cramp and other occupational cramps, symptomatic hemidystonia and hemiparesis due to stroke | Q45634274 | ||
Decreased dopamine D receptor binding in essential blepharospasm | Q46550187 | ||
Sepiapterin reductase deficiency: a congenital dopa-responsive motor and cognitive disorder | Q46622458 | ||
Quetiapine in the treatment of focal tardive dystonia induced by other atypical antipsychotics: a report of 2 cases | Q46630490 | ||
The spectrum of disorders presenting as adult-onset focal lower extremity dystonia | Q46711470 | ||
“Motor circuit” gray matter changes in idiopathic cervical dystonia | Q47392987 | ||
Task-specific plasticity of somatosensory cortex in patients with writer's cramp | Q47433793 | ||
A common point mutation in the tyrosine hydroxylase gene in autosomal recessive L-DOPA-responsive dystonia in the Dutch population | Q47690346 | ||
[3H]-2-deoxyglucose uptake study in mutant dystonic hamsters: abnormalities in discrete brain regions of the motor system | Q47756198 | ||
Cerebellar circuitry is activated during convulsive episodes in the tottering (tg/tg) mutant mouse | Q47930717 | ||
Deep brain stimulation for primary generalized dystonia: long-term outcomes | Q48012076 | ||
Late onset of cervical dystonia in a 39-year-old patient following cerebellar hemorrhage | Q48087719 | ||
Manual activity shapes structure and function in contralateral human motor hand area | Q48090427 | ||
Delayed-onset oromandibular dystonia after a cerebellar hemorrhagic stroke | Q48096478 | ||
Structural abnormalities in the cerebellum and sensorimotor circuit in writer's cramp | Q48097572 | ||
Abnormal plasticity of sensorimotor circuits extends beyond the affected body part in focal dystonia | Q48103335 | ||
Cellular effects of deep brain stimulation: model-based analysis of activation and inhibition | Q48119729 | ||
Neuroanatomical substrates for paroxysmal dyskinesia in lethargic mice | Q48140345 | ||
Dopamine receptor upregulation in Lesch-Nyhan syndrome: a postmortem study | Q48166440 | ||
Pallidal stimulation modifies after-effects of paired associative stimulation on motor cortex excitability in primary generalised dystonia | Q48170100 | ||
Bilateral striatal necrosis associated with a novel mutation in the mitochondrial ND6 gene | Q48183315 | ||
Forward genetic screen of mouse reveals dominant missense mutation in the P/Q-type voltage-dependent calcium channel, CACNA1A. | Q48233446 | ||
Paroxysmal torticollis and blepharospasm following bilateral cerebellar infarction | Q48312130 | ||
The natural history of tardive dystonia. A long-term follow-up study of 107 cases | Q48343307 | ||
Focal myoclonus-dystonia of the leg secondary to a lesion of the posterolateral putamen: clinical and neurophysiological features. | Q48346981 | ||
Writer's cramp: restoration of striatal D2-binding after successful biofeedback-based sensorimotor training | Q48369153 | ||
Abnormal plasticity of the sensorimotor cortex to slow repetitive transcranial magnetic stimulation in patients with writer's cramp | Q48377026 | ||
Abnormalities in motor cortical plasticity differentiate manifesting and nonmanifesting DYT1 carriers | Q48381491 | ||
Functional brain networks in DYT1 dystonia | Q48389410 | ||
Basal ganglia arteriovenous malformation presenting as "writer's cramp". | Q48416831 | ||
Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia. | Q48436385 | ||
Functional magnetic resonance imaging study of writer's cramp | Q48443595 | ||
Confirmation that a T-to-C mutation at 9176 in mitochondrial DNA is an additional candidate mutation for Leigh's syndrome | Q48446459 | ||
Digit-specific aberrations in the primary somatosensory cortex in Writer's cramp | Q48462988 | ||
The basal ganglia are hyperactive during the discrimination of tactile stimuli in writer's cramp. | Q48467756 | ||
Imaging the pre- and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: a SPECT study using [123I] epidepride and [123I] beta-CIT. | Q48491525 | ||
Long-term effects of pallidal deep brain stimulation in tardive dystonia | Q48546624 | ||
Changes in perfusion pattern using ECD-SPECT indicate frontal lobe and cerebellar involvement in exercise-induced paroxysmal dystonia | Q48549653 | ||
High frequency stimulation of the entopeduncular nucleus sets the cortico-basal ganglia network to a new functional state in the dystonic hamster | Q48583184 | ||
Globus pallidus internus pallidotomy for generalized dystonia | Q48586235 | ||
Changes in forearm reciprocal inhibition following pallidal stimulation for dystonia | Q48587698 | ||
Childhood and adolescent forms of Huntington's disease | Q37136818 | ||
Hypoxanthine-guanine phosphoribosyl transferase regulates early developmental programming of dopamine neurons: implications for Lesch-Nyhan disease pathogenesis | Q37223253 | ||
Disordered plasticity in the primary somatosensory cortex in focal hand dystonia | Q37300286 | ||
Dopamine agonists and antagonists in the treatment of idiopathic dystonia | Q39512496 | ||
Parkinsonism following dystonia in three patients | Q39545869 | ||
Abnormal somatotopic arrangement of sensorimotor interactions in dystonic patients | Q39635574 | ||
Late-onset episodic ataxia type 2 associated with a novel loss-of-function mutation in the CACNA1A gene. | Q39881404 | ||
Moldy Sugarcane Poisoning— A Case Report with a Brief Review | Q40457230 | ||
Focal limb dystonia in a patient with a cerebellar mass | Q40598916 | ||
Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene | Q41187721 | ||
Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia | Q41620234 | ||
SPECT abnormalities in generalized dystonia | Q41670394 | ||
Partial cytochrome b deficiency and generalized dystonia | Q41772734 | ||
Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. | Q41899842 | ||
End-of-dose dystonia in Parkinson's disease | Q42289191 | ||
Electron transfer complex I defect in idiopathic dystonia | Q42457019 | ||
Striatal increase of extracellular dopamine levels during dystonic episodes in a genetic model of paroxysmal dyskinesia | Q42463401 | ||
Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeys | Q42488566 | ||
Autosomal dominant dystonia-plus with cerebral calcifications | Q42500150 | ||
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 | ||
Morphometric changes of sensorimotor structures in focal dystonia | Q42511369 | ||
Presynaptic dopaminergic deficits in Lesch-Nyhan disease | Q42517524 | ||
Abnormal cerebellar signaling induces dystonia in mice. | Q42525204 | ||
Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation | Q42526865 | ||
Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. | Q42590497 | ||
Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs | Q42652856 | ||
Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder | Q42658736 | ||
Chronic deep brain stimulation in patients with tardive dystonia without a history of major psychosis | Q42970938 | ||
Long-term benefit sustained after bilateral pallidal deep brain stimulation in patients with refractory tardive dystonia | Q43001378 | ||
Mechanisms underlying striatal vulnerability to 3-nitropropionic acid | Q43061451 | ||
Central levodopa influx and the clinical motor response to levodopa in patients with Parkinson disease complicated with motor fluctuations and dyskinesias. | Q43294945 | ||
Sixty hertz pallidal deep brain stimulation for primary torsion dystonia | Q43640625 | ||
Triggers of paroxysmal dyskinesia in the calcium channel mouse mutant tottering | Q44084758 | ||
MELAS syndrome with mitochondrial tRNA(Leu)(UUR) mutation: correlation of clinical state, nerve conduction, and muscle 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin | Q44244041 | ||
Long-term efficacy and safety of chronic globus pallidus internus stimulation in different types of primary dystonia | Q44434632 | ||
Hereditary spastic dystonia: a new mitochondrial encephalopathy? Putaminal necrosis as a diagnostic sign | Q48713960 | ||
The metabolic topography of essential blepharospasm: a focal dystonia with general implications | Q48714455 | ||
Cervical dystonia associated with tumors of the posterior fossa | Q48717493 | ||
Early morning off-medication dyskinesias, dystonia, and choreic subtypes | Q48790625 | ||
Subthalamic nucleus deep brain stimulation in primary cervical dystonia | Q48895732 | ||
Writers' cramp-a focal dystonia | Q48904328 | ||
Basal ganglia and thalamo-cortical hypermetabolism in patients with spasmodic torticollis | Q48925163 | ||
Cerebral activation patterns in patients with writer's cramp: a functional magnetic resonance imaging study. | Q48942587 | ||
Abnormal perception of the tonic vibration reflex in idiopathic focal dystonia | Q49051448 | ||
Biochemical Evidence of Dysfunction of Brain Neurotransmitters in the Lesch-Nyhan Syndrome | Q49159972 | ||
A novel intronic mutation in the DDP1 gene in a family with X-linked dystonia-deafness syndrome. | Q50474839 | ||
Characteristics of sensory trick-like manoeuvres in jaw-opening dystonia. | Q51083549 | ||
The behavioural and motor consequences of focal lesions of the basal ganglia in man. | Q51132485 | ||
Tonic vibration reflex and muscle afferent block in writer's cramp. | Q51597388 | ||
Deficient homeostatic regulation of practice-dependent plasticity in writer's cramp. | Q51897195 | ||
Abnormal vibration-induced illusion of movement in idiopathic focal dystonia: an endophenotypic marker? | Q51971138 | ||
Sepiapterin reductase deficiency an autosomal recessive DOPA-responsive dystonia. | Q52019134 | ||
Trick maneuvers in cervical dystonia: investigation of movement- and touch-related changes in polymyographic activity. | Q53957067 | ||
Clozapine treatment of spasmodic torticollis. | Q54029558 | ||
Benign paroxysmal tonic upgaze, benign paroxysmal torticollis, episodic ataxia and CACNA1A mutation in a family | Q57812159 | ||
Risperidone in idiopathic and symptomatic dystonia: preliminary experience | Q58452085 | ||
Mutations in the Cacnl1a4 calcium channel gene are associated with seizures, cerebellar degeneration, and ataxia in tottering and leaner mutant mice | Q61981684 | ||
Clinical and polymyographic investigation of spasmodic torticollis | Q68066040 | ||
H-reflex recovery curve and reciprocal inhibition of H-reflex in different kinds of dystonia | Q68762761 | ||
Motor control in childhood onset dopa-responsive dystonia (Segawa syndrome) | Q69264181 | ||
Regional cerebral glucose utilization reveals widespread abnormalities in the motor system of the rat mutant dystonic | Q69386587 | ||
Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists | Q69541978 | ||
Selective elimination of cerebellar output in the genetically dystonic rat | Q70983169 | ||
GTP-cyclohydrolase I gene mutations in hereditary progressive amd dopa-responsive dystonia | Q71053671 | ||
Antidystonic effects of L-type Ca2+ channel antagonists in a hamster model of idiopathic dystonia | Q71343543 | ||
Torticollis acquired in late infancy due to a cerebellar gangliocytoma | Q71523448 | ||
Delayed dystonia with striatal CT lucencies induced by a mycotoxin (3-nitropropionic acid) | Q71631143 | ||
The treatment of dystonia with L-dopa and haloperidol | Q71724110 | ||
Torsion dystonia and spasmodic torticollis results of treatment with L-dopa | Q71724112 | ||
Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles | Q71843083 | ||
Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid | Q72098398 | ||
Tardive dystonia: Late-onset and persistent dystonia caused by antipsychotic drugs | Q72540335 | ||
NADH-CoQ reductase deficient myopathy: successful treatment with riboflavin | Q72560397 | ||
Treatment of complex I deficiency with riboflavin | Q72576684 | ||
The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome | Q72632067 | ||
Dopamine D2 receptor imaging with iodine-123-iodobenzamide SPECT in idiopathic rotational torticollis | Q72880198 | ||
Complex I function in familial and sporadic dystonia | Q73282830 | ||
Sensory tricks in cervical dystonia: perceptual dysbalance of parietal cortex modulates frontal motor programming | Q73546533 | ||
Calcium channel agonists and dystonia in the mouse | Q73832413 | ||
Clinical characteristics of the geste antagoniste in cervical dystonia | Q74353278 | ||
Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNA1A mutation | Q74575755 | ||
Sensory modulation of the blink reflex in patients with blepharospasm | Q77308709 | ||
Chronic high-frequency globus pallidus internus stimulation in different types of dystonia: a clinical, video, and MRI report of six patients presenting with segmental, cervical, and generalized dystonia | Q77614979 | ||
Laryngeal dystonia as a presenting symptom of young-onset Parkinson's disease | Q79371089 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1387-1403 | |
P577 | publication date | 2011-12-03 | |
P1433 | published in | Expert Opinion on Therapeutic Targets | Q5421214 |
P1476 | title | Convergent mechanisms in etiologically-diverse dystonias | |
P478 | volume | 15 |
Q36568475 | A dystonia-like movement disorder with brain and spinal neuronal defects is caused by mutation of the mouse laminin β1 subunit, Lamb1. |
Q27317321 | ATP1A3 Mutation in Adult Rapid-Onset Ataxia |
Q35913791 | Alternative approaches to modeling hereditary dystonias |
Q26830473 | Diagnosis and treatment of dystonia |
Q34254159 | Dystonia type 6 gene product Thap1: identification of a 50 kDa DNA-binding species in neuronal nuclear fractions |
Q48163760 | Non-invasive brain stimulation for dystonia: therapeutic implications |
Q38780028 | Novel Dystonia Genes: Clues on Disease Mechanisms and the Complexities of High-Throughput Sequencing |
Q35692168 | Reduced Number of Pigmented Neurons in the Substantia Nigra of Dystonia Patients? Findings from Extensive Neuropathologic, Immunohistochemistry, and Quantitative Analyses |
Q46481280 | The Anatomical Basis for Dystonia: The Motor Network Model |
Q34626729 | The New Classification System for the Dystonias: Why Was it Needed and How was it Developed? |
Q37070290 | The focal dystonias: current views and challenges for future research |
Q52987127 | Thiamine and dystonia 16. |
Search more.